Market Tracker

08/30 5:16pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.1261
Delayed Data
As of Aug 30
 +0.0026 / +2.11%
Today’s Change
0.11
Today|||52-Week Range
0.59
-64.51%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.12
Today’s open0.13
Day’s range0.12 - 0.13
Volume4,392,865
Average volume (3 months)1,112,758
Market cap$15.8M
Dividend yield--
Data as of 4:02pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)-26.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.51

Competitors

 Today’s
change
Today’s
% change
HTGMHTG Molecular Diagno...-0.03-1.18%
FSIFlexible Solutions I...+0.01+0.55%
BASIBioanalytical System...-0.08-6.72%
ABACAoxin Tianli Group I...0.000.00%
Data as of 3:59pm ET, 08/30/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Principal Financial &
Accounting Officer
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts